Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
1.5%
1w
0.3%
1m
7.8%
3m
22.4%
6m
5.7%
1y
27.5%
all
12.0%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,291 1.5%
1,013
1,408
Company Overview
Sales
1,055 Cr
Growth: 4.0%
Profit after Tax
261 Cr
Growth: -16.5%
Mid Cap
13,501 Cr
P/E: 52.1x
Industry P/E: 33.7x
Fundamentals
Sales (Cr) ₹ 1,055
Growth 4.0%
EBITDA 34.8%
P/S 12.8x
Dividend 0.6%
P/E 52.1x
Book Value ₹ 193
PEG Ratio 13.0x
ROE 13.4%
P/B 6.7x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (23 Indices) view more
Followers (1)
varsha96